Indivior Pharmaceuticals, Inc.
Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market. (via Wikipedia)
Market & Alt Data
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-27 | 2026-08-27 | Anderson Woodrow D | Chief Accounting Officer | Purchase | 1,500 | $35.69 | $54K | 27.6K | View | |
| 2026-08-05 | 2026-08-05 | Anderson Woodrow D | Chief Accounting Officer | Purchase | 1,500 | $36.28 | $54K | 26.1K | View | |
| 2026-07-10 | 2026-07-13 | Heidbreder Christian | Chief Scientific Officer | Sale | 18.6K | $41.14 | $765K | 209.3K | View | |
| 2026-06-11 | 2026-06-12 | Heidbreder Christian | Chief Scientific Officer | Sale | 18.6K | $38.06 | $707K | 227.9K | View | |
| 2026-03-13 | 2026-03-13 | Ryan Barbara | Director | Purchase | 8 | $31.09 | $248.68 | 5,724 | View |
Informational purposes only, not investment advice.
tormere.com/research/INDV · generated 2026-11-04
Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-08-27 | Anderson Woodrow D | P | 1,500 | $53,535 |
| 2026-08-05 | Anderson Woodrow D | P | 1,500 | $54,420 |
| 2026-07-10 | Heidbreder Christian | S | 18,586 | $764,628.04 |
| 2026-06-11 | Heidbreder Christian | S | 18,586 | $707,383.16 |
| 2026-03-13 | Ryan Barbara | P | 8 | $248.68 |
Tormere — informational purposes only, not investment advice.
| Filed | Items | Filing |
|---|---|---|
Nov 3, 2026 accepted 9:10 AM ET | 8.01Other events | DocumentSEC ↗ |
Nov 2, 2026 accepted 9:27 AM ET | 1.01Material agreement2.01Acquisition / disposition2.03New debt obligation5.02Officer / director change5.03Bylaws / fiscal year7.01Reg FD disclosure | DocumentSEC ↗ |
Oct 29, 2026 accepted 7:00 AM ET | 2.02Earnings release | DocumentSEC ↗ |